CVS Caremark (CVS) saw broad sales growth in Q4, with Pharmacy Services revenue up 5.2% and Retail Pharmacy sales growth of 5.6%.
Retail Pharmacy Segment same store sales rose 4.0% during the period.
Gross profit rate fell 60 bps to 30.7%.
The company expects 2014 EPS of $4.36-$4.50 vs. $4.47 consensus.
A conference call is scheduled for 8:30 am where more details on the company's exit from tobacco could be discussed. (webcast)
CVS +0.7% premarket